Human OSGEP/GAMOS3/GCPL1 ORF/cDNA clone-Lentivirus plasmid (NM_017807)
Cat. No.: pGMLP004420
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human OSGEP/GAMOS3/GCPL1 Lentiviral expression plasmid for OSGEP lentivirus packaging, OSGEP lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
OSGEP/GAMOS3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP004420 |
Gene Name | OSGEP |
Accession Number | NM_017807 |
Gene ID | 55644 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 1008 bp |
Gene Alias | GAMOS3,GCPL1,KAE1,OSGEP1,PRSMG1,TCS3 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGCCGGCGGTGCTGGGTTTTGAAGGCAGCGCCAATAAGATTGGCGTGGGCGTGGTGCGGGATGGCAAGGTGCTGGCGAACCCGCGGCGGACTTACGTCACGCCTCCTGGCACAGGATTCCTTCCAGGTGATACAGCCAGGCATCACCGAGCTGTTATCCTAGACCTGCTGCAGGAGGCACTAACAGAGTCTGGATTAACCTCCCAGGATATCGACTGCATTGCATACACCAAGGGCCCTGGCATGGGTGCCCCACTGGTTTCTGTGGCTGTTGTGGCCCGTACTGTGGCCCAACTGTGGAATAAGCCATTGGTGGGTGTGAACCACTGTATAGGCCACATTGAGATGGGCCGCCTCATCACTGGAGCCACCAGCCCAACCGTGTTGTATGTGAGTGGAGGAAATACGCAGGTGATTGCATACTCGGAACATCGTTACCGTATCTTTGGGGAAACCATCGATATTGCAGTGGGTAATTGTCTGGATCGTTTTGCTCGAGTGCTGAAGATTTCTAACGACCCAAGTCCAGGATACAACATTGAACAGATGGCAAAGCGAGGCAAGAAGCTAGTTGAGCTGCCATACACTGTAAAGGGGATGGACGTCTCATTCTCAGGGATCCTGTCTTTCATTGAGGATGTAGCCCATCGGATGCTGGCCACAGGCGAGTGTACTCCTGAGGATCTGTGTTTCTCCCTGCAGGAAACTGTGTTTGCAATGCTGGTAGAGATCACAGAGCGAGCCATGGCACATTGTGGCTCCCAGGAGGCCCTCATTGTGGGAGGAGTGGGGTGTAATGTGAGGCTACAGGAGATGATGGCAACAATGTGCCAGGAACGTGGAGCCCGGCTTTTTGCTACAGATGAGAGATTCTGTATTGACAATGGAGCGATGATAGCCCAGGCTGGCTGGGAGATGTTTCGGGCTGGACACAGGACCCCACTCAGTGATTCTGGGGTTACACAGAGGTATCGGACAGATGAAGTAGAGGTGACCTGGAGGGACTAA |
ORF Protein Sequence | MPAVLGFEGSANKIGVGVVRDGKVLANPRRTYVTPPGTGFLPGDTARHHRAVILDLLQEALTESGLTSQDIDCIAYTKGPGMGAPLVSVAVVARTVAQLWNKPLVGVNHCIGHIEMGRLITGATSPTVLYVSGGNTQVIAYSEHRYRIFGETIDIAVGNCLDRFARVLKISNDPSPGYNIEQMAKRGKKLVELPYTVKGMDVSFSGILSFIEDVAHRMLATGECTPEDLCFSLQETVFAMLVEITERAMAHCGSQEALIVGGVGCNVRLQEMMATMCQERGARLFATDERFCIDNGAMIAQAGWEMFRAGHRTPLSDSGVTQRYRTDEVEVTWRD |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP2226-Ab | Anti-OSGEP/ GAMOS3/ GCPL1 monoclonal antibody |
Target Antigen | GM-Tg-g-MP2226-Ag | OSGEP VLP (virus-like particle) |
ORF Viral Vector | pGMLP004420 | Human OSGEP Lentivirus plasmid |
ORF Viral Vector | vGMLP004420 | Human OSGEP Lentivirus particle |
Target information
Target ID | GM-MP2226 |
Target Name | OSGEP |
Gene ID | 55644, 66246, 702512, 290028, 101101062, 100687555, 507512, 100058606 |
Gene Symbol and Synonyms | 1500019L24Rik,GAMOS3,GCPL-1,GCPL1,KAE1,OSGEP,OSGEP1,PRSMG1,TCS3 |
Uniprot Accession | Q9NPF4 |
Uniprot Entry Name | OSGEP_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000092094 |
Target Classification | Not Available |
Predicted to enable N(6)-L-threonylcarbamoyladenine synthase activity and metal ion binding activity. Involved in tRNA threonylcarbamoyladenosine modification. Located in cytoplasm; nuclear speck; and plasma membrane. Part of EKC/KEOPS complex. Implicated in Galloway-Mowat syndrome 3. [provided by Alliance of Genome Resources, Apr 2022]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.